biotech · Acute Myeloid Leukemia (AML) · Ovarian Cancer · STRO
SUTRO BIOPHARMA
SUTRO BIOPHARMA, INC.
SUTRO BIOPHARMA trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
South San Francisco, USA HQ
2003 Founded
212 Employees
Public company Type
STRO · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2003
- Employees
- 212
- Programs
- 10
- Drugs
- 21
- Patents
- 34
SUTRO BIOPHARMA clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to SUTRO BIOPHARMA programs — each row shows trial ID, program name, phase, status, and indication.
SUTRO BIOPHARMA trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for SUTRO BIOPHARMA.
-
STRO-002-GM3 — Phase 2
Clinical update -
STRO-002-GM2 — Phase 1
Clinical update -
REFRaME-P1 — Phase 2
Clinical update -
STRO-004 — Phase 1
Clinical update -
STRO-002 — Phase 1
Clinical update -
STRO-002 — Phase 2
Clinical update -
STRO-001 — Phase 1
Clinical update -
Luveltamab tazevibulin — Phase 3
Clinical update
Trial registry
-
CTIS ↗ - 2024-512477-27-00CTIS ↗
STRO-002-GM3
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
- 2024-513708-33-00CTIS ↗
STRO-002-GM2
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗